semaglutide cardiovascular outcomes study 2025 news and by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial GLP-1 Studies Add to Growing

Wegovy and Ozempic are FDA-approved branded medications

As a result, compounded semaglutide may have inconsistencies in dosage, effectiveness, and safety, potentially introducing harmful impurities or inaccurate dosing

Originally developed to manage type 2 diabetes, researchers noticed a significantand welcomeside effect: substantial weight loss

Geetika Arora, an endocrinologist at Northwell's Phelps Hospital, puts it simply: "The trade-off comes down to convenience versus maximum weight loss." In a Lilly-funded trial published by The Lancet, patients on 12 to 36 milligrams of orforglipron lost an average of 15 to 20 pounds, compared with 8 to 11 pounds for those on 7 to 14 milligrams of Rybelsus